NPs Basic Information
|
Name |
Stachyline E
|
| Molecular Formula | C13H18O5 | |
| IUPAC Name* |
2-[4-(2,3-dihydroxy-3-methylbutoxy)phenyl]aceticacid
|
|
| SMILES |
CC(C)(O)C(O)COc1ccc(CC(=O)O)cc1
|
|
| InChI |
InChI=1S/C13H18O5/c1-13(2,17)11(14)8-18-10-5-3-9(4-6-10)7-12(15)16/h3-6,11,14,17H,7-8H2,1-2H3,(H,15,16)/t11-/m0/s1
|
|
| InChIKey |
ZZVAFINHVIXFPI-NSHDSACASA-N
|
|
| Synonyms |
NA
|
|
| CAS | NA | |
| PubChem CID | NA | |
| ChEMBL ID | NA |
*Note: the IUPAC Name was calculated by STOUT. Reference: PMID:33906675.
Chemical Classification: |
|
|
|---|
——————————————————————————————————————————
NPs Species Source
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
NPs Biological Activity
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
NPs Physi-Chem Properties
| Molecular Weight: | 254.28 | ALogp: | 0.8 |
| HBD: | 3 | HBA: | 4 |
| Rotatable Bonds: | 6 | Lipinski's rule of five: | Accepted |
| Polar Surface Area: | 87.0 | Aromatic Rings: | 1 |
| Heavy Atoms: | 18 | QED Weighted: | 0.711 |
——————————————————————————————————————————
NPs ADMET Properties*
ADMET: Absorption
| Caco-2 Permeability: | -5.184 | MDCK Permeability: | 0.00066541 |
| Pgp-inhibitor: | 0 | Pgp-substrate: | 0.031 |
| Human Intestinal Absorption (HIA): | 0.024 | 20% Bioavailability (F20%): | 0.003 |
| 30% Bioavailability (F30%): | 0.01 |
——————————————————————————————————————————
ADMET: Distribution
| Blood-Brain-Barrier Penetration (BBB): | 0.285 | Plasma Protein Binding (PPB): | 73.63% |
| Volume Distribution (VD): | 0.145 | Fu: | 28.86% |
——————————————————————————————————————————
ADMET: Metabolism
| CYP1A2-inhibitor: | 0.036 | CYP1A2-substrate: | 0.049 |
| CYP2C19-inhibitor: | 0.022 | CYP2C19-substrate: | 0.298 |
| CYP2C9-inhibitor: | 0.021 | CYP2C9-substrate: | 0.957 |
| CYP2D6-inhibitor: | 0.012 | CYP2D6-substrate: | 0.292 |
| CYP3A4-inhibitor: | 0.007 | CYP3A4-substrate: | 0.13 |
——————————————————————————————————————————
ADMET: Excretion
| Clearance (CL): | 6.812 | Half-life (T1/2): | 0.796 |
——————————————————————————————————————————
ADMET: Toxicity
| hERG Blockers: | 0.032 | Human Hepatotoxicity (H-HT): | 0.098 |
| Drug-inuced Liver Injury (DILI): | 0.875 | AMES Toxicity: | 0.077 |
| Rat Oral Acute Toxicity: | 0.027 | Maximum Recommended Daily Dose: | 0.007 |
| Skin Sensitization: | 0.089 | Carcinogencity: | 0.262 |
| Eye Corrosion: | 0.003 | Eye Irritation: | 0.034 |
| Respiratory Toxicity: | 0.006 |
——————————————————————————————————————————
*Note: the ADMET properties was calculated by ADMETlab 2.0. Reference: PMID: 33893803.
Similar Compounds*
Compounds similar to EMNPD with top10 similarity:
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC005263 |  |
1.000 | D01UXC |  |
0.493 | ||
| ENC005827 |  |
0.532 | D02HXS |  |
0.431 | ||
| ENC005828 |  |
0.532 | D03XTC |  |
0.413 | ||
| ENC000074 |  |
0.493 | D02AQY |  |
0.410 | ||
| ENC000006 |  |
0.472 | D0VB0U |  |
0.394 | ||
| ENC005261 |  |
0.471 | D0KD1U |  |
0.389 | ||
| ENC003949 |  |
0.460 | D0I2MK |  |
0.384 | ||
| ENC005262 |  |
0.403 | D0B3QM |  |
0.371 | ||
| ENC001338 |  |
0.400 | D0Y7EM |  |
0.343 | ||
| ENC005220 |  |
0.382 | D03ROX |  |
0.341 | ||